Skip to main content
. 2012 Mar 6;32(4):663–669. doi: 10.1007/s10875-012-9656-5

Table III.

Temporally associated adverse events (TAAEs) in more than 5% patients in the safety population (N = 63)

AE By Patient (n,%) (47 patients) By Infusion (n,%) (431 infusions)
Headache 27 (42.9%) 115 (15.4%)
Fatigue 15 (23.8%) 59 (7.9%)
Infusion site reaction 5 (7.9%) 5 (0.7%)
Nausea 5 (7.9%) 8 (1.1%)
Blood Pressure increased 4 (6.3%) 5 (0.7%)
Diarrhea 4 (6.3%) 4 (0.5%)
Dizziness 4 (6.3%) 4 (0.5%)
Lethargy 4 (6.3%) 4 (0.5%)